Heart failure & cardiomyopathies
Global Differences in Acute Heart Failure Treatment: Analysis of the STRONG-HF Site Feasibility Questionnaire
Authors' conclusion
In this analysis of feasibility questionnaires, most sites reported general adherence to ESC guidelines for treatment and management of AHF patients although percutaneous and device therapy was less common outside Europe and follow-up after discharge took place late and was not as extensive as recommended.
Study context
- Population
- Sites approached for the STRONG-HF study treating acute heart failure, February 2018–May 2021sites in 20 countries
- Participants
- 158 participants
- Exposure
- In-hospital acute heart failure (AHF) treatment and management across five regions vs ESC guidelines
- Outcome
- Standard in-hospital AHF treatment and management compared with current clinical guidelines and across regions
Methodological detailssite feasibility questionnaire, multicentre, 158 sites in 20 countries
- Site feasibility questionnaire
- Multicentre
- 158 sites in 20 countries
Main finding
As reported in the abstract
- Significant regional differences in reported % of AHF patients receiving ACEi, mostly due to more ARB and ARNI prescription in South America and Western Europe
- P < 0.001
Observational data: associations, not effects.
Original publication
Global Differences in Acute Heart Failure Treatment: Analysis of the STRONG-HF Site Feasibility Questionnaire. ESC Heart Fail. Published 19 April 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →